ERS/ESICM/ESCMID/ALAT 重症社区获得性肺炎管理指南
欧洲呼吸学会等四家机构组成18名欧洲和4名非欧洲专家及2名方法学家的专家组,针对重症社区获得性肺炎的8个临床问题制定首部国际指南。系统检索多个数据库,采用GRADE评估证据质量,通过EtD框架形成诊断、抗生素、器官支持、生物标志物和辅助治疗推荐。
要点
- 首部国际重症社区获得性肺炎指南,由ERS/ESICM/ESCMID/ALAT联合制定
- 围绕诊断、抗生素、器官支持、生物标志物和辅助治疗8个临床问题给出推荐
- 采用GRADE方法评估证据质量,EtD框架决定推荐方向和强度
核心结论
- ERS、ESICM、ESCMID和ALAT基于GRADE方法为重症社区获得性肺炎的诊断、经验性治疗和抗生素治疗提供循证临床实践推荐。
- 指南同时指出当前知识空白并提出未来研究方向。
研究设计与样本
- 由ERS、ESICM、ESCMID和ALAT组建工作组制定首部重症社区获得性肺炎国际指南。
- 专家组包括18名欧洲和4名非欧洲专家及2名方法学家,选择8个诊断和治疗临床问题。
- 在多个数据库进行系统文献检索,尽可能进行Meta分析合成证据,采用GRADE评估证据质量,使用EtD框架决定推荐方向和强度。
主要发现
- 推荐涉及诊断、抗生素、器官支持、生物标志物和辅助治疗。
- 推荐的形成考虑了效应估计的置信度、研究结局的重要性、治疗的可取与不良后果、成本、可行性、可接受性及对健康公平的影响。
临床怎么用
- 临床可依据该国际指南对重症社区获得性肺炎进行诊断、经验性治疗和抗生素治疗决策。
局限性
- 指南指出现有知识空白,并据此提出未来研究建议。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Severe community-acquired pneumonia (sCAP) is associated with high morbidity and mortality, and while European and non-European guidelines are available for community-acquired pneumonia, there are no specific guidelines for sCAP. MATERIALS AND METHODOLOGY: The European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Latin American Thoracic Association (ALAT) launched a task force to develop the first international guidelines for sCAP. The panel comprised a total of 18 European and four non-European experts, as well as two methodologists. Eight clinical questions for sCAP diagnosis and treatment were chosen to be addressed. Systematic literature searches were performed in several databases. Meta-analyses were performed for evidence synthesis, whenever possible. The quality of evidence was assessed with GRADE (Grading of Recommendations, Assessment, Development and Evaluation). Evidence to Decision frameworks were used to decide on the direction and strength of recommendations. RESULTS: Recommendations issued were related to diagnosis, antibiotics, organ support, biomarkers and co-adjuvant therapy. After considering the confidence in effect estimates, the importance of outcomes studied, desirable and undesirable consequences of treatment, cost, feasibility, acceptability of the intervention and implications to health equity, recommendations were made for or against specific treatment interventions. CONCLUSIONS: In these international guidelines, ERS, ESICM, ESCMID and ALAT provide evidence-based clinical practice recommendations for diagnosis, empirical treatment and antibiotic therapy for sCAP, following the GRADE approach. Furthermore, current knowledge gaps have been highlighted and recommendations for future research have been made.
引用
- Martin-Loeches, Torres, Nagavci, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Eur Respir J. 2023. PMID: 37012080. doi:10.1183/13993003.00735-2022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。